Home About NAKFI Conferences Grants Communication Awards Contact Us My Account
Synthetic Biology Home
Steering Committee Members
IDR Team Challenge Summaries
Podcast Tutorials
Conference Agenda
Grants
Conference Photos

Login to manage your account and access the NAFKI Alumni Network.

Password Reminder









J. Craig Venter
J.Craig Venter (NAS)
 
Dr. Venter is also Founder and CEO of Synthetic Genomics Inc., a privately held company dedicated to commercializing genomic-driven solutions to address global energy and environmental challenges.
 
Dr. Venter began his formal education after a tour of duty as a Navy Corpsman in Vietnam from 1967 to 1968.  After earning both a Bachelor’s degree in Biochemistry and a Ph.D. in Physiology and Pharmacology from the University of California at San Diego, he was appointed professor at the State University of New York at Buffalo and the Roswell Park Cancer Institute.  In 1984, he moved to the National Institutes of Health campus where he developed Expressed Sequence Tags or ESTs, a revolutionary new strategy for rapid gene discovery.  In 1992 Dr. Venter founded The Institute for Genomic Research (TIGR), a not-for-profit research institute (now part of the JCVI), where in 1995 he and his team decoded the genome of the first free-living organism, the bacterium Haemophilus influenzae, using his new whole genome shotgun technique.  Dr. Venter and his teams have gone on to sequence hundreds of genomes using these powerful techniques and tools.
 
In 1998, Dr. Venter founded Celera Genomics to sequence the human genome using new tools and techniques he and his team developed.  The successful completion of this research culminated with the February 2001 publication of the human genome in the journal, Science. He and his team at Celera also sequenced the fruit fly, mouse and rat genomes.  Dr. Venter and his team at the Venter Institute continue to blaze new trails in genomics research and have published numerous important papers covering such areas as environmental genomics, synthetic genomics and the first complete diploid human genome in 2007.
 
Dr. Venter, one of the most frequently cited scientists, is the author of more than 200 research articles. He is also the recipient of numerous honorary degrees, public honors, and scientific awards, including the 2001 Paul Ehrlich and Ludwig Darmstaedter Prize, and the 2002 Gairdner Foundation International Award. Dr. Venter is a member of numerous prestigious scientific organizations including the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Society for Microbiology.